That the House of Representatives— (1) expresses support for the designation of DES Awareness Week; (2) recognizes the history of the drug diethylstilbestrol and the harm it has caused; (3) supports the restoration of funding for the DES Follow-Up Study; and (4) urges the Food and Drug Administration to issue a formal apology to families impacted by diethylstilbestrol.